Literature DB >> 9571536

HPTLC analysis of sphingomylein, ceramide and sphingosine in ischemic/reperfused rat heart.

G A Cordis1, T Yoshida, D K Das.   

Abstract

Since the sphingomylein-ceramide-sphingosine pathway, especially ceramide, has been shown to induce programmed cell death (apoptosis), and since apoptosis may be involved with ischemic/reperfused injury in the heart, it became desirable to quantitate the three components in ischemic/reperfused rat heart. One group of rat hearts (n = 6) was isolated and perfused with Krebs-Henseleit buffer using the Langendorff non-recirculating mode. The hearts were perfused for 10 min, made ischemic for 30 min and reperfused for 120 min. Hearts were collected and stored at - 70 degrees C before ischemia, after ischemia and after 30, 60 and 120 min of reperfusion. The hearts were homogenized, and lipids were extracted using the Folch method. The lipids were then chromatographed on Whatman silica gel 60 A high-performance thin-layered chromatography (HPTLC) plates. The plates were developed with iodine, photographed using Photoshop software and quantitated using NIH Imaging software. The results show a 50% decrease of sphingomylein during reperfusion with a corresponding increase in ceramide with sphingosine showing a smaller decrease as compared with the ceramide increase.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9571536     DOI: 10.1016/s0731-7085(97)00260-4

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  19 in total

Review 1.  Sphingolipidomics: methods for the comprehensive analysis of sphingolipids.

Authors:  Christopher A Haynes; Jeremy C Allegood; Hyejung Park; M Cameron Sullards
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-12-31       Impact factor: 3.205

2.  Generation of survival signal by differential interaction of p38MAPKalpha and p38MAPKbeta with caveolin-1 and caveolin-3 in the adapted heart.

Authors:  Manika Das; Jianhua Cui; Dipak K Das
Journal:  J Mol Cell Cardiol       Date:  2006-10-25       Impact factor: 5.000

Review 3.  Sphingolipids and Lipoproteins in Health and Metabolic Disorders.

Authors:  Jahangir Iqbal; Meghan T Walsh; Samar M Hammad; M Mahmood Hussain
Journal:  Trends Endocrinol Metab       Date:  2017-04-24       Impact factor: 12.015

Review 4.  Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology.

Authors:  Catherine Pavoine; Françoise Pecker
Journal:  Cardiovasc Res       Date:  2009-01-28       Impact factor: 10.787

Review 5.  The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases.

Authors:  Eric L Smith; Edward H Schuchman
Journal:  FASEB J       Date:  2008-06-20       Impact factor: 5.191

6.  Myocardial infarction changes sphingolipid metabolism in the uninfarcted ventricular wall of the rat.

Authors:  Małgorzata Knapp; Małgorzata Zendzian-Piotrowska; Krzysztof Kurek; Agnieszka Błachnio-Zabielska
Journal:  Lipids       Date:  2012-07-26       Impact factor: 1.880

7.  Induction of the matricellular protein CCN1 through RhoA and MRTF-A contributes to ischemic cardioprotection.

Authors:  Xia Zhao; Eric Y Ding; Olivia M Yu; Sunny Y Xiang; Valerie P Tan-Sah; Bryan S Yung; Joe Hedgpeth; Richard R Neubig; Lester F Lau; Joan Heller Brown; Shigeki Miyamoto
Journal:  J Mol Cell Cardiol       Date:  2014-08-08       Impact factor: 5.000

8.  Sphingolipid regulators of cellular dysfunction in Type 2 diabetes mellitus: a systems overview.

Authors:  Jessica S Ross; Sarah B Russo; Georgia C Chavis; Lauren A Cowart
Journal:  Clin Lipidol       Date:  2017-01-18

Review 9.  Ceramide and mitochondria in ischemia/reperfusion.

Authors:  Sergei A Novgorodov; Tatyana I Gudz
Journal:  J Cardiovasc Pharmacol       Date:  2009-03       Impact factor: 3.105

10.  Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat.

Authors:  Małgorzata Knapp; Małgorzata Zendzian-Piotrowska; Agnieszka Błachnio-Zabielska; Piotr Zabielski; Krzysztof Kurek; Jan Górski
Journal:  Basic Res Cardiol       Date:  2012-09-09       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.